ISDA

Deposition Date 2007-12-06

Release Date 2008-01-29

Last Version Date 2024-10-16

Entry Detail

PDB ID:

2VIZ

Keywords:

HYDROLASE

Title:

Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2-oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

CRICETULUS GRISEUS

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.60 Å

R-Value Free:

0.22

R-Value Work:

0.19

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:BETA-SECRETASE 1
Gene (Uniprot):BACE1
Mutations:YES
Chain IDs:A
Chain Length:392
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P56817 Pfam ID:PF00026 EC:3.4.23.46

Ligand Molecules

VG4

Primary Citation

Bace-1 Inhibitors Part 1: Identification of Novel Hydroxy Ethylamines (Heas).

Clarke, B, Demont, E, Dingwall, C, Dunsdon, R, Faller, A, Hawkins, J, Hussain, I, Macpherson, D, Maile, G, Matico, R, Milner, P, Mosley, J, Naylor, A, O'Brien, A, Redshaw, S, Riddell, D, Rowland, P, Soleil, V, Smith, K, Stanway, S, Stemp, G, Sweitzer, S, Theobald, P, Vesey, D, Walter, D.S, Ward, J, Wayne, G.Show

Bioorg.Med.Chem.Lett. 18 1011 ? (2008)

PMID: 18171614 DOI: 10.1016/J.BMCL.2007.12.017

Abstact

Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. Herein, is described the lead generation effort which resulted, with the support of X-ray crystallography, in the discovery of potent inhibitors based on a hydroxy ethylamine (HEA) transition-state mimetic. These inhibitors were capable of lowering amyloid production in a cell-based assay.

Legend

Protein

Chemical

Disease

Primary Citation of related structures